| 2501 |
Apheresis |
Allogeneic |
Pre-B-Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2502 |
Apheresis |
Allogeneic |
Pre-B-Acute Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2503 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2504 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
73 |
| 2505 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Germany |
70 |
| 2506 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2507 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2508 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
31 |
| 2509 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2510 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Germany |
46 |
| 2511 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2512 |
Apheresis |
Allogeneic |
Relapsed B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2513 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2514 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
58 |
| 2515 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
36 |
| 2516 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2517 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
9 |
| 2518 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2519 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2520 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2521 |
Apheresis |
Allogeneic |
Systemic Mastocytosis |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2522 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2523 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2524 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2525 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2526 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
18 |
| 2527 |
Apheresis |
Allogeneic |
T-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2528 |
Apheresis |
Allogeneic |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2529 |
Apheresis |
Allogeneic |
Treatment-Related Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2530 |
Apheresis |
Allogeneic |
Treatment-Related Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2531 |
Apheresis |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2532 |
Skeletal Muscle |
Allogeneic – Related |
Duchenne Muscular Dystrophy (DMD) |
Genetic disorder |
2022 |
Experimental Therapy |
Poland |
15 |
| 2533 |
Skeletal Muscle |
Allogeneic – Related |
Duchenne Muscular Dystrophy (DMD) |
Genetic disorder |
2022 |
Experimental Therapy |
Poland |
6 |
| 2534 |
Skeletal Muscle |
Allogeneic – Related |
Duchenne Muscular Dystrophy (DMD) |
Genetic disorder |
2022 |
Experimental Therapy |
Poland |
12 |
| 2535 |
Skeletal Muscle |
Allogeneic – Related |
Duchenne Muscular Dystrophy (DMD) |
Genetic disorder |
2022 |
Experimental Therapy |
Poland |
7 |
| 2536 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2022 |
Experimental Therapy |
Poland |
2 |
| 2537 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Experimental Therapy |
Poland |
4,6 |
| 2538 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Experimental Therapy |
Poland |
5,4 |
| 2539 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2022 |
Experimental Therapy |
Poland |
42,8 |
| 2540 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2022 |
Experimental Therapy |
Poland |
60,5 |
| 2541 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2022 |
Experimental Therapy |
Poland |
69,7 |
| 2542 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2022 |
Experimental Therapy |
Poland |
70,5 |
| 2543 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2022 |
Experimental Therapy |
Poland |
54,2 |
| 2544 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2022 |
Experimental Therapy |
Poland |
76,1 |
| 2545 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
6,3 |
| 2546 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
9,1 |
| 2547 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,9 |
| 2548 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,3 |
| 2549 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,8 |
| 2550 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7 |
| 2551 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
12,8 |
| 2552 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,1 |
| 2553 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
5,3 |
| 2554 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
4,8 |
| 2555 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7 |
| 2556 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2022 |
Experimental Therapy |
Romania |
14 |
| 2557 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
4,9 |
| 2558 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,6 |
| 2559 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
6,9 |
| 2560 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,6 |
| 2561 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
5,5 |
| 2562 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,4 |
| 2563 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
6,11 |
| 2564 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,5 |
| 2565 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland/Romania |
6,7 |
| 2566 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,8 |
| 2567 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
6,8 |
| 2568 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland/Romania |
8 |
| 2569 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
13,7 |
| 2570 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland/Romania |
10,2 |
| 2571 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,4 |
| 2572 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
6,2 |
| 2573 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
12,4 |
| 2574 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
10,4 |
| 2575 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
6,11 |
| 2576 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
5,3 |
| 2577 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,5 |
| 2578 |
Cord Tissue |
Allogeneic – Unrelated |
Bone Marrow Transplant Rejection |
Hematology |
2022 |
Experimental Therapy |
Poland |
2,5 |
| 2579 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
8 |
| 2580 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,3 |
| 2581 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
12,3 |
| 2582 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,5 |
| 2583 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,6 |
| 2584 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,4 |
| 2585 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,5 |
| 2586 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
5,11 |
| 2587 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,4 |
| 2588 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,1 |
| 2589 |
Cord Tissue |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Romania |
3 |
| 2590 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,9 |
| 2591 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,8 |
| 2592 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
1,5 |
| 2593 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,4 |
| 2594 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
3,3 |
| 2595 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
11,8 |
| 2596 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
5 |
| 2597 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
7 |
| 2598 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,5 |
| 2599 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
Poland |
1,8 |
| 2600 |
Cord Tissue |
Allogeneic – Unrelated |
Duchenne Muscular Dystrophy (Dmd) |
Neurology |
2022 |
Experimental Therapy |
Poland |
21,2 |